Indrajit Fernando

2.4k total citations
48 papers, 1.3k citations indexed

About

Indrajit Fernando is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Indrajit Fernando has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Cancer Research and 13 papers in Surgery. Recurrent topics in Indrajit Fernando's work include Breast Cancer Treatment Studies (15 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Ovarian cancer diagnosis and treatment (7 papers). Indrajit Fernando is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Ovarian cancer diagnosis and treatment (7 papers). Indrajit Fernando collaborates with scholars based in United Kingdom, Switzerland and United States. Indrajit Fernando's co-authors include Daniel Rea, Lucinda Billingham, Andrew Stanley, Peter Simmonds, Simon Gollins, Claire Gaunt, S. Bowden, Neil Steven, Mark Bower and Michael Cullen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Indrajit Fernando

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indrajit Fernando United Kingdom 15 702 489 291 264 198 48 1.3k
Wolfgang Janni Germany 22 350 0.5× 307 0.6× 156 0.5× 161 0.6× 73 0.4× 88 1.2k
Ivor Benjamin United States 22 469 0.7× 314 0.6× 681 2.3× 151 0.6× 196 1.0× 45 1.8k
Enora Laas France 21 585 0.8× 350 0.7× 59 0.2× 184 0.7× 175 0.9× 97 1.5k
A.A.M. Hart Netherlands 20 633 0.9× 446 0.9× 247 0.8× 408 1.5× 91 0.5× 32 1.6k
Atif A Hashmi Pakistan 22 461 0.7× 336 0.7× 65 0.2× 228 0.9× 93 0.5× 136 1.4k
P. Buytaert Belgium 17 260 0.4× 203 0.4× 110 0.4× 128 0.5× 154 0.8× 47 1.2k
John H. Maduro Netherlands 29 678 1.0× 939 1.9× 103 0.4× 519 2.0× 126 0.6× 89 2.3k
Angela Musella Italy 23 376 0.5× 132 0.3× 256 0.9× 163 0.6× 198 1.0× 75 1.5k
Henry G. Kaplan United States 22 831 1.2× 396 0.8× 113 0.4× 325 1.2× 112 0.6× 79 1.6k
Punita Lal India 21 374 0.5× 219 0.4× 62 0.2× 278 1.1× 109 0.6× 85 1.1k

Countries citing papers authored by Indrajit Fernando

Since Specialization
Citations

This map shows the geographic impact of Indrajit Fernando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indrajit Fernando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indrajit Fernando more than expected).

Fields of papers citing papers by Indrajit Fernando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indrajit Fernando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indrajit Fernando. The network helps show where Indrajit Fernando may publish in the future.

Co-authorship network of co-authors of Indrajit Fernando

This figure shows the co-authorship network connecting the top 25 collaborators of Indrajit Fernando. A scholar is included among the top collaborators of Indrajit Fernando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indrajit Fernando. Indrajit Fernando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernando, Indrajit, Siân Lax, S. Bowden, et al.. (2023). Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity. Clinical Oncology. 35(6). 397–407. 1 indexed citations
2.
Fernando, Indrajit, S. Bowden, Cassandra Brookes, et al.. (2019). Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. Radiotherapy and Oncology. 142. 52–61. 10 indexed citations
3.
Walji, Nawaz, et al.. (2015). Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.. PubMed. 35(9). 4841–7. 3 indexed citations
4.
King, Margaret, et al.. (2015). Survival and Toxicity Following Chemoradiation for Carcinoma of the Cervix - Impact of Multiple-phase Treatment and Shielding.. PubMed. 35(10). 5567–74. 1 indexed citations
5.
McCormack, Mary, Latha Kadalayil, Allan Hackshaw, et al.. (2013). A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. British Journal of Cancer. 108(12). 2464–2469. 92 indexed citations
6.
Fernando, Indrajit, Richard Fox, Rob Grieve, et al.. (2011). 5122 POSTER Effect of Synchronous Chemo-radiation on Quality of Life: Results From the SECRAB Trial (ISRCTN: 84214355) Presented on Behalf of the SECRAB Steering Committee. European Journal of Cancer. 47. S366–S366. 2 indexed citations
7.
Mitra, Arijit, Matthew R. Edmunds, Nawaz Walji, et al.. (2011). Reversible branch retinal artery occlusion following intravenous cisplatin chemotherapy for cervical carcinoma. International Ophthalmology. 31(5). 429–432. 7 indexed citations
8.
Walji, Nawaz, Christina Yap, Linda Rogers, et al.. (2010). Is There a Role for Adjuvant Hysterectomy after Suboptimal Concurrent Chemoradiation in Cervical Carcinoma?. Clinical Oncology. 22(2). 140–146. 14 indexed citations
9.
Cullen, Michael, Neil Steven, Lucinda Billingham, et al.. (2005). Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas. New England Journal of Medicine. 353(10). 988–998. 275 indexed citations
12.
Moss, Esther L., Andrew Stevens, Linda Gray, C. McConkey, & Indrajit Fernando. (2003). Toxicity, Recurrence and Survival after Adjuvant Radiotherapy Treatment for FIGO Stage I Cancer of the Endometrium. Clinical Oncology. 15(5). 250–254. 3 indexed citations
13.
Fernando, Indrajit. (2000). The Role of Radiotherapy in Patients Undergoing Mastectomy for Carcinoma of the Breast. Clinical Oncology. 12(3). 158–165. 8 indexed citations
14.
Fernando, Indrajit, et al.. (1998). Intratumoral focused chemotherapy with cisplatin/ epinephrine injectable gel for palliative treatment of metastatic breast cancer. European Journal of Cancer. 34. S21–S21. 1 indexed citations
15.
Fernando, Indrajit, H.T. Ford, T.J. Powles, et al.. (1996). Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital. Clinical Oncology. 8(4). 226–233. 90 indexed citations
16.
Fernando, Indrajit, et al.. (1995). The effect of head and neck irradiation on taste dysfunction: A prospective study. Clinical Oncology. 7(3). 173–178. 52 indexed citations
17.
Fernando, Indrajit, T.J. Powles, A G Nash, et al.. (1995). Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 426(2). 155–61. 11 indexed citations
18.
Fernando, Indrajit, et al.. (1994). Is there still a role for lymphography in the management of early stage carcinoma of the cervix?. British Journal of Radiology. 67(803). 1052–1056.
19.
Fernando, Indrajit, et al.. (1993). Immunocytochemical Staining For the C‐Erbb‐2 Gene Product In Breast Aspirates: A Preliminary Report. Cytopathology. 4(4). 219–224. 4 indexed citations
20.
Fernando, Indrajit, et al.. (1993). Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen. British Journal of Cancer. 67(4). 706–712. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026